Catriona Thomson
About Catriona Thomson
Catriona Thomson is a Senior Director of Clinical Operations at Nektar Therapeutics, with a background in medical genetics and extensive experience in project management within the clinical research sector.
Current Role at Nektar Therapeutics
Catriona Thomson serves as the Senior Director of Clinical Operations at Nektar Therapeutics. She has held this position since 2021, contributing to the strategic oversight and management of clinical trials. Her role involves ensuring compliance with regulatory standards and optimizing clinical processes to enhance operational efficiency.
Previous Experience in Clinical Operations
Before joining Nektar Therapeutics, Catriona Thomson worked at Chiltern in various capacities. She progressed from Project Manager to Senior Project Manager and ultimately to Global Project Manager between 2012 and 2018. Her responsibilities included leading project teams and managing clinical trial operations across multiple projects.
Educational Background in Genetics
Catriona Thomson studied at The University of Glasgow, where she earned a Bachelor of Science with Honours in Genetics from 1998 to 2002. She furthered her education by obtaining a Master of Science in Medical Genetics in 2003. This academic background has provided her with a strong foundation in genetic research and clinical applications.
Experience in Clinical Research Associate Roles
Catriona Thomson has extensive experience in clinical research associate roles. She worked at PAREXEL as a Senior Clinical Research Associate from 2004 to 2007 and at Eisai in a similar capacity from 2007 to 2008. These positions involved monitoring clinical trials and ensuring adherence to protocols and regulatory requirements.
Research Experience
Earlier in her career, Catriona Thomson worked as a Research Assistant at the Muscular Dystrophy Campaign from 2003 to 2004. This role involved supporting research initiatives aimed at understanding muscular dystrophy, contributing to her expertise in the field of medical research.